Publications

  1. Levy CJ, Raghinaru D, Kudva YC, Pandit K, Blevins T, Casaubon L, Desjardins D, Levister CM, O'Malley G, Reid C, Lum J, Kollman C, Beck RW. Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes. Clin Diabetes. 2024 Winter; 42 (1):116-124 Epub 2023 Aug 28
    View PubMed
  2. Benhalima K, Mathieu C, Napoli A, Kudva YC, Cypryk K, Hammond P, Cukierman-Yaffe T, Cyganek K, Divakar H, Hod M. Safe Options for the Treatment of Mothers and Babies with Pregestational Diabetes. Diabetes Technol Ther. 2024 Nov 6 Epub 2024 Nov 06
    View PubMed
  3. Long JJ, Sahi SS, Lemke AI, Na J, Garcia Valencia OA, Budhiraja P, Wadei HM, Sudhindran V, Benzo R, Clark MM, Shah M, Fipps D, Navratil P, Abdelrheem AA, Shaik AA, Duffy DJ, Pencovici N, Pencovich N, Shah P, Kudva YC, Kukla A, Diwan TS. The Use of Semaglutide in Patients With Renal Failure-A Retrospective Cohort Study. Endocr Pract. 2024 Oct; 30 (10):963-969 Epub 2024 July 16
    View PubMed
  4. Costa DN, Kudva YC, Jensen MD, Shah P. Clinical Utility of Serum C-Peptide Concentration for Hospitalized Patients with Hyperglycemia. Diabetes Technol Ther. 2024 Sep 20 Epub 2024 Sept 20
    View PubMed
  5. Kaur RJ, Perez J, Young L, Miller P, Hirsch IB, Beck RW, Marak MC, Calhoun P, Mottalib A, Salhin A, Manessis A, Coviello AD, Bhargava A, Thorsell A, Atakov Castillo A, Bode BW, Levister C, Levy CJ, Donahue C, Cordero C, Beatson C, Langel CR, Jacobson C, Kurek C, Cruse D, Pickering D, Tamarez D, Steenkamp DW, Desjardins D, Aleppo G, O'Malley G, Akturk HK, Diner J, Baran JD, Buse JB, Ruedy K, Codorniz K, Klein KR, Castorino K, Jordan LF, Kipnes M, Church MM, Hamdy O, Raskin P, Nguyen QT, Weinstock RS, Lee S, Rizvi S, Bzdick S, Ghorbani Rodriguez T, Salah T, Blevins T, Kudva YC, Haider Z, INHALE-3 Study Group. A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery. Diabetes Care. 2024 Sep 1; 47 (9):1682-1687
    View PubMed
  6. Beck RW, Levy CJ, Kudva YC, Pandit K, Blevins T, Raghinaru D, Pinsker JE. Beneficial Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use With Control-IQ Technology in Type 2 Diabetes. Clin Diabetes. 2024 Fall; 42 (4):547-549 Epub 2024 Apr 17
    View PubMed
  7. Fonseca LM, Kanapka L, Miller K, Pratley R, Rickels MR, Rizvi S, Kudva YC, Weinstock RS, Chaytor NS. Risk factors associated with cognitive performance and cognitive impairment in older adults with type 1 diabetes: Data from the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study. J Diabetes Complications. 2024 May; 38 (5):108739 Epub 2024 Mar 26
    View PubMed
  8. Kukla A, Sahi SS, Navratil P, Benzo RP, Smith BH, Duffy D, Park WD, Shah M, Shah P, Clark MM, Fipps DC, Denic A, Schinstock CA, Dean PG, Stegall MD, Kudva YC, Diwan TS. Weight Loss Surgery Increases Kidney Transplant Rates in Patients With Renal Failure and Obesity. Mayo Clin Proc. 2024 May; 99 (5):705-715
    View PubMed
  9. Kaur RJ, Levy CJ, Castorino K, Wood-Wentz CM, Rizvi SR, Ozaslan B, O'Malley G, Trinidad MC, Levister C, Church MM, Desjardins D, Ogyaadu S, Reid C, Bailey KR, Doyle FJ 3rd, Pinsker JE, Dassau E, Kudva YC. Concordance of Blood Glucose and CGM During a Pilot Trial of Automated Insulin Delivery in Type 1 Diabetes Pregnancies. J Endocr Soc. 2024 Apr 6; 8 (6):bvae071 Epub 2024 Apr 15
    View PubMed
  10. Hawks ZW, Beck ED, Jung L, Fonseca LM, Sliwinski MJ, Weinstock RS, Grinspoon E, Xu I, Strong RW, Singh S, Van Dongen HPA, Frumkin MR, Bulger J, Cleveland MJ, Janess K, Kudva YC, Pratley R, Rickels MR, Rizvi SR, Chaytor NS, Germine LT. Dynamic associations between glucose and ecological momentary cognition in Type 1 Diabetes. NPJ Digit Med. 2024 Mar 18; 7 (1):59
    View PubMed
  11. Drachenberg CB, Buettner-Herold M, Aguiar PV, Horsfield C, Mikhailov AV, Papadimitriou JC, Seshan SV, Perosa M, Boggi U, Uva P, Rickels M, Grzyb K, Arend L, Cuatrecasas M, Toniolo MF, Farris AB, Renaudin K, Zhang L, Roufousse C, Gruessner A, Gruessner R, Kandaswamy R, White S, Burke G, Cantarovich D, Parsons RF, Cooper M, Kudva YC, Kukla A, Haririan A, Parajuli S, Merino-Torres JF, Argente-Pla M, Meier R, Dunn T, Ugarte R, Rao JS, Vistoli F, Stratta R, Odorico J. Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell-mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods. Am J Transplant. 2024 Mar; 24 (3):362-379 Epub 2023 Oct 21
    View PubMed
  12. Kukla A, Kudva YC, Navratil P, Sahi SS, Benzo RP, Fipps DC, Erickson AE, Majorowicz RR, Clark MM, Schinstock CA, Shah P, Shah M, Diwan TS. Management of Patients With Kidney Disease Undergoing Bariatric Surgery: A Multidisciplinary Approach. Mayo Clin Proc. 2024 Mar; 99(3):445-458.
    View PubMed
  13. Drachenberg CB, Buettner-Herold M, Aguiar PV, Horsfield C, Mikhailov AV, Papadimitriou JC, Seshan S, Perosa M, Boggi U, Uva P, Rickels M, Grzyb K, Arend L, Cuatrecasas M, Toniolo MF, Farris AB, Renaudin K, Zhang L, Roufousse C, Gruessner A, Gruessner R, Kandaswamy R, White S, Burke G, Cantarovich D, Parsons RF, Cooper M, Kudva YC, Kukla A, Haririan A, Parajuli S, Merino-Torres J, Argente-Pla M, Meier R, Dunn T, Ugarte R, Rao JS, Vistoli F, Stratta R, Odorico J. Banff 2022 pancreas transplantation multidisciplinary report: refinement of guidelines for t cell-mediated rejection, antibody-mediated rejection and islet pathology. assessment of duodenal cuff biopsies and noninvasive diagnostic methods. American Journal of Transplantation. 2024 Mar; 24 (3):362-79
  14. Yetmar ZA, Kudva YC, Seville MT, Bosch W, Huskey JL, Jarmi T, Kukla A, Dean PG, Razonable RR, Beam E. Risk of cytomegalovirus infection and subsequent allograft failure after pancreas transplantation. Am J Transplant. 2024 Feb; 24 (2):271-279 Epub 2023 Oct 13
    View PubMed
  15. Kaur RJ, Mujtahedi SS, Fridell JA, Benavides X, Smith B, Larson TS, Rizvi SR, Kukla A, Dean P, Kudva YC, Odorico J, Stegall M. Impact of pancreas transplantation alone on kidney function: A multicenter clinical cohort study. Clin Transplant. 2024 Jan; 38 (1):e15212 Epub 2023 Dec 01
    View PubMed
  16. Majorowicz RR, Attia A, Bamlet HM, Clegg DJ, Diwan T, Erickson AE, Kudva YC, Levy S, Paramesh AS, Tatum D, Kukla A, Collaborative on Obesity Research in Transplantation (CORT). Nutritional Considerations for Patients With Renal Failure Undergoing Sleeve Gastrectomy. J Ren Nutr. 2024 Jan; 34 (1):76-86 Epub 2023 Aug 19
    View PubMed
  17. Yetmar ZA, Kudva YC, Seville MT, Bosch W, Dean PG, Huskey JL, Budhiraja P, Jarmi T, Kukla A, Beam E. BK polyomavirus DNAemia in pancreas transplant recipients compared to pancreas-kidney recipients. Clin Transplant. 2023 Nov; 37 (11):e15135 Epub 2023 Sept 13
    View PubMed
  18. Ekhlaspour L, Raghinaru D, Forlenza GP, Isganaitis E, Kudva YC, Lam DW, Levister C, O'Malley G, Church MM, Lum JW, Buckingham B, Brown SA. Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial. J Diabetes Sci Technol. 2023 Jul; 17 (4):935-942 Epub 2022 Apr 26
    View PubMed
  19. Benhalima K, Beunen K, Siegelaar SE, Painter R, Murphy HR, Feig DS, Donovan LE, Polsky S, Buschur E, Levy CJ, Kudva YC, Battelino T, Ringholm L, Mathiesen ER, Mathieu C. Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets. Lancet Diabetes Endocrinol. 2023 Jul; 11 (7):490-508 Epub 2023 June 05
    View PubMed
  20. Levy CJ, Kudva YC, Ozaslan B, Castorino K, O'Malley G, Kaur RJ, Levister CM, Church MM, Desjardins D, McCrady-Spitzer S, Ogyaadu S, Trinidad MC, Reid C, Rizvi S, Deshpande S, Zaniletti I, Kremers WK, Pinsker JE, Doyle FJ, Dassau E, LOIS-P Diabetes and Pregnancy Consortium. At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter Study. Diabetes Care. 2023 Jul 01; 46(7):1425-1431.
    View PubMed
  21. Yetmar ZA, McCord M, Lahr BD, Kudva YC, Seville MT, Bosch W, Lemke A, Katariya NN, Reddy KS, Perry DK, Huskey JL, Jarmi T, Kukla A, Dean PG, Bernard SA, Beam E. Impact of Perioperative Prophylaxis With Enterococcus Activity on Risk of Surgical-Site Infection After Pancreas Transplantation. Transplant Direct. 2023 Jul; 9(7):e1496. Epub 2023 Jun 08.
    View PubMed
  22. Rizvi SR, Kaur RJ, Kudva YC. Time in Range Goal is Achieved in a Unique Way. Mayo Clin Proc. 2023 May; 98 (5):748-749
    View PubMed
  23. Hart PA, Kudva YC, Yadav D, Andersen DK, Li Y, Toledo FGS, Wang F, Bellin MD, Bradley D, Brand RE, Cusi K, Fisher W, Mather K, Park WG, Saeed Z, Considine RV, Graham SC, Rinaudo JA, Serrano J, Goodarzi MO. A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes. J Clin Endocrinol Metab. 2023 Apr 13; 108 (5):e120-e128
    View PubMed
  24. Schiavon M, Galderisi A, Basu A, Kudva YC, Cengiz E, Dalla Man C. A New Index of Insulin Sensitivity from Glucose Sensor and Insulin Pump Data: In Silico and In Vivo Validation in Youths with Type 1 Diabetes. Diabetes Technol Ther. 2023 Apr; 25 (4):270-278 Epub 2023 Feb 17
    View PubMed
  25. Christensen JD, Kohlenberg JD, Kudva YC. 46-Year-Old Woman With Type 2 Diabetes Mellitus and Obesity. Mayo Clin Proc. 2023 Jan; 98 (1):181-186
    View PubMed
  26. Lange S, Simha V, Desjardins D, Garg SK, Grunberger G, Weinstock R, Lawson ML, Hirsch IB, DiMeglio LA, Pop-Busui R, Philis-Tsimikas A, Kipnes M, Liljenquist DR, Brazg RL, Kudva YC, Buckingham BA, McGill JB, Carlson AL, Criego AB, Christiansen MP, Kaiserman KB, Griffin KJ, Forlenza GP, Bode BW, Slover RH, Keiter A, Ling C, Marinos B, Cordero TL, Shin J, Lee SW, Rhinehart AS, Vigersky RA, Adult and Pediatric MiniMed HCL Outcomes 6-month RCT: HCL versus CSII Control Study Group. Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial. Diabetes Technol Ther. 2023 Jan; 25 (1):1-12 Epub 2022 Dec 20
    View PubMed
  27. Wright DE, Mukherjee S, Patra A, Khasawneh H, Korfiatis P, Suman G, Chari ST, Kudva YC, Kline TL, Goenka AH. Radiomics-based machine learning (ML) classifier for detection of type 2 diabetes on standard-of-care abdomen CTs: a proof-of-concept study. Abdom Radiol (NY). 2022 Nov; 47 (11):3806-3816 Epub 2022 Sept 10
    View PubMed
  28. Pinsker JE, Dassau E, Deshpande S, Raghinaru D, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Church MM, Desrochers H, Ekhlaspour L, Kaur RJ, Levister C, Shi D, Lum JW, Kollman C, Doyle FJ, iDCL Trial Research Group. Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4. Diabetes Technol Ther. 2022 Sep; 24(9):635-642. Epub 2022 Jun 02.
    View PubMed
  29. Kukla A, Diwan T, Smith BH, Collazo-Clavell ML, Lorenz EC, Clark M, Grothe K, Denic A, Park WD, Sahi S, Schinstock CA, Amer H, Issa N, Bentall AJ, Dean PG, Kudva YC, Mundi M, Stegall MD. Guiding Kidney Transplantation Candidates for Effective Weight Loss: A Clinical Cohort Study. Kidney360. 2022 Aug 25; 3(8):1411-1416. Epub 2022 May 16.
    View PubMed
  30. Lemke A, Brokmeier HM, Leung SB, Mara KC, Mour GK, Wadei HM, Hill JM, Stegall M, Kudva YC, Shah P, Kukla A. Sodium-glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation. Clin Transplant. 2022 Aug; 36 (8):e14718 Epub 2022 May 30
    View PubMed
  31. Kaur RJ, Smith BH, Ozaslan B, Pinsker JE, Trinidad MC, O'Malley G, Desjardins D, Castorino KN, Levister C, Reid C, McCrady-Spitzer S, Ogyaadu SJ, Church MM, Piper M, Kremers WK, Rosenn B, Doyle FJ 3rd, Dassau E, Levy CJ, Kudva YC. Hypoglycemia in Prospective Multicenter Study of Pregnancies with Pre-Existing Type 1 Diabetes on Sensor-Augmented Pump Therapy: The LOIS-P Study. Diabetes Technol Ther. 2022 Aug; 24(8):544-555.
    View PubMed
  32. Brazg R, Garg SK, Bhargava A, Thrasher JR, Latif K, Bode BW, Bailey TS, Horowitz BS, Cavale A, Kudva YC, Kaiserman KB, Grunberger G, Reed JC, Chattaraj S, Zhang G, Shin J, Chen V, Lee SW, Cordero TL, Rhinehart AS, Vigersky RA, Buckingham BA. Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial. Diabetes Technol Ther. 2022 Aug; 24 (8):535-543 Epub 2022 Mar 24
    View PubMed
  33. Ozaslan B, Levy CJ, Kudva YC, Pinsker JE, O'Malley G, Kaur RJ, Castorino K, Levister C, Trinidad MC, Desjardins D, Church MM, Plesser M, McCrady-Spitzer S, Ogyaadu S, Nelson K, Reid C, Deshpande S, Kremers WK, Doyle FJ , III, Rosenn B, Dassau E. Feasibility of Closed-Loop Insulin Delivery with a Pregnancy-Specific Zone Model Predictive Control Algorithm. Diabetes Technol Ther. 2022 Jul; 24(7):471-480. Epub 2022 Apr 26.
    View PubMed
  34. Miller KM, Kanapka LG, Rickels MR, Ahmann AJ, Aleppo G, Ang L, Bhargava A, Bode BW, Carlson A, Chaytor NS, Gannon G, Goland R, Hirsch IB, Kiblinger L, Kruger D, Kudva YC, Levy CJ, McGill JB, O'Malley G, Peters AL, Philipson LH, Philis-Tsimikas A, Pop-Busui R, Salam M, Shah VN, Thompson MJ, Vendrame F, Verdejo A, Weinstock RS, Young L, Pratley R. Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes. Diabetes Technol Ther. 2022 Jun; 24 (6):424-434 Epub 2022 Apr 11
    View PubMed
  35. Kaur RJ, Deshpande S, Pinsker JE, Gilliam WP, McCrady-Spitzer S, Zaniletti I, Desjardins D, Church MM, Doyle Iii FJ, Kremers WK, Dassau E, Kudva YC. Outpatient Randomized Crossover Automated Insulin Delivery Versus Conventional Therapy with Induced Stress Challenges. Diabetes Technol Ther. 2022 May; 24(5):338-349. Epub 2022 Apr 25.
    View PubMed
  36. Levy CJ, O'Malley G, Raghinaru D, Kudva YC, Laffel LM, Pinsker JE, Lum JW, Brown SA, iDCL Trial Research Group. Insulin Delivery and Glucose Variability Throughout the Menstrual Cycle on Closed Loop Control for Women with Type 1 Diabetes. Diabetes Technol Ther. 2022 May; 24(5):357-361. Epub 2022 Feb 21.
    View PubMed
  37. Kotwal A, Rouleau SG, Dasari S, Kottschade L, Ryder M, Kudva YC, Markovic S, Erickson D. Immune checkpoint inhibitor-induced hypophysitis: lessons learnt from a large cancer cohort. J Investig Med. 2022 Apr; 70 (4):939-946 Epub 2021 Dec 29
    View PubMed
  38. Jeet Kaur R, Rizvi SR, Reid C, Johnson BK, Smith BH, McCrady-Spitzer SK, Kremers WK, Dean P, Kukla A, Stegall MD, Kudva YC. P.138: Patients Report Improved Diabetes Distress After Successful Pancreas Transplantation. Transplantation. 2021 Dec 1; 105 (12 Suppl 2):S56
    View PubMed
  39. Jeet Kaur R, Rizvi SR, Reid C, Johnson BK, Smith BH, McCrady-Spitzer SK, Kremers WK, Dean P, Kukla A, Stegall MD, Kudva YC. P.140: Impact of Successful Pancreas Transplantation on Patient Reported Hypoglycemia Outcomes. Transplantation. 2021 Dec 1; 105 (12 Suppl 2):S57
    View PubMed
  40. Rizvi SR, Kaur RJ, Dadlani V, Almodallal Y, Reid CL, Smith BH, Kremers W, Kukla A, Stegall MD, Sadighi Akha AA, Kudva YC. P.155: Altered T Cell Compartment in Type 1 Diabetes With End Stage Renal Disease. Transplantation. 2021 Dec 1; 105 (12 Suppl 2):S63-S64
    View PubMed
  41. Rizvi SR, Kaur RJ, Dadlani V, Almodallal Y, Reid CL, Smith BH, Kremers W, Kukla A, Stegall MD, Akha AAS, Kudva YC. P.157: NK and B Cell Subset Assessment in Type I Diabetes Patients on Waitlist for Pancreas Transplantation. Transplantation. 2021 Dec 1; 105 (12 Suppl 2):S65
    View PubMed
  42. O'Malley G, Ozaslan B, Levy CJ, Castorino K, Desjardins D, Levister C, McCrady-Spitzer S, Church MM, Kaur RJ, Reid C, Kremers WK, Doyle FJ, Trinidad MC, Rosenn B, Pinsker JE, Kudva YC, Dassau E. Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study. Diabetes Technol Ther. 2021 Dec; 23(12):807-817. Epub 2021 Aug 17.
    View PubMed
  43. King RL, Khurana A, Mwangi R, Fama A, Ristow KM, Maurer MJ, Macon WR, Ansell SM, Bennani NN, Kudva YC, Walker RC, Watt KD, Schwab TR, Kushwaha SS, Cerhan JR, Habermann TM. Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria. Hemasphere. 2021 Oct; 5 (10):e640 Epub 2021 Sept 06
    View PubMed
  44. Kudva YC, Laffel LM, Brown SA, Raghinaru D, Pinsker JE, Ekhlaspour L, Levy CJ, Messer LH, Kovatchev BP, Lum JW, Beck RW, Gonder-Frederick L, iDCL Trial Research Group. Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial. Diabetes Technol Ther. 2021 Oct; 23(10):673-683.
    View PubMed
  45. Cescon M, Choudhary D, Pinsker JE, Dadlani V, Church MM, Kudva YC, Doyle Iii FJ, Dassau E. Activity detection and classification from wristband accelerometer data collected on people with type 1 diabetes in free-living conditions. Comput Biol Med. 2021 Aug; 135:104633 Epub 2021 July 12
    View PubMed
  46. Carlson AL, Kanapka LG, Miller KM, Ahmann AJ, Chaytor NS, Fox S, Kiblinger L, Kruger D, Levy CJ, Peters AL, Rickels MR, Salam M, Shah VN, Young LA, Kudva YC, Pratley R, WISDM Study Group. Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study. J Diabetes Sci Technol. 2021 May; 15 (3):582-592 Epub 2019 Dec 21
    View PubMed
  47. Isganaitis E, Raghinaru D, Ambler-Osborn L, Pinsker JE, Buckingham BA, Wadwa RP, Ekhlaspour L, Kudva YC, Levy CJ, Forlenza GP, Beck RW, Kollman C, Lum JW, Brown SA, Laffel LM, iDCL Trial Research Group. Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial. Diabetes Technol Ther. 2021 May; 23 (5):342-349 Epub 2021 Jan 21
    View PubMed
  48. O'Malley G, Messer LH, Levy CJ, Pinsker JE, Forlenza GP, Isganaitis E, Kudva YC, Ekhlaspour L, Raghinaru D, Lum J, Brown SA, iDCL Trial Research Group. Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial. Diabetes Technol Ther. 2021 Apr; 23(4):245-252.
    View PubMed
  49. Creo AL, Cortes TM, Jo HJ, Huebner AR, Dasari S, Tillema JM, Lteif AN, Klaus KA, Ruegsegger GN, Kudva YC, Petersen RC, Port JD, Nair KS. Brain functions and cognition on transient insulin deprivation in type 1 diabetes. JCI Insight. 2021 Mar 08; 6(5).
    View PubMed
  50. Singh P, Razonable RR, Lorenz EC, DiCaudo DJ, Sukov WR, Bridges AG, Alkhateeb HB, Hogan WJ, Klomjit N, Thirunavukkarasu S, Amer H, Kudva YC, Khamash H, Stegall M, Kukla A. Chronic graft-versus-host disease in pancreas after kidney transplant recipients - An unrecognized entity. Am J Transplant. 2021 Feb; 21 (2):883-888 Epub 2020 Sept 20
    View PubMed
  51. Kukla A, Alexander MP, Turkevi-Nagy S, Merzkani M, Park W, Smith B, Zhang P, Benavides X, D'Costa M, Morales Alvarez C, Denic A, Bentall A, Kudva YC, Stegall M. Mesangial expansion at 5 years predicts death and death-censored graft loss after renal transplantation. Clin Transplant. 2021 Jan; 35 (1):e14147 Epub 2020 Nov 24
    View PubMed
  52. Brown SA, Beck RW, Raghinaru D, Buckingham BA, Laffel LM, Wadwa RP, Kudva YC, Levy CJ, Pinsker JE, Dassau E, Doyle FJ 3rd, Ambler-Osborn L, Anderson SM, Church MM, Ekhlaspour L, Forlenza GP, Levister C, Simha V, Breton MD, Kollman C, Lum JW, Kovatchev BP, iDCL Trial Research Group. Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2020 Aug; 43 (8):1822-1828 Epub 2020 May 29
    View PubMed
  53. Pratley RE, Kanapka LG, Rickels MR, Ahmann A, Aleppo G, Beck R, Bhargava A, Bode BW, Carlson A, Chaytor NS, Fox DS, Goland R, Hirsch IB, Kruger D, Kudva YC, Levy C, McGill JB, Peters A, Philipson L, Philis-Tsimikas A, Pop-Busui R, Shah VN, Thompson M, Vendrame F, Verdejo A, Weinstock RS, Young L, Miller KM, Wireless Innovation for Seniors With Diabetes Mellitus (WISDM) Study Group. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020 Jun 16; 323 (23):2397-2406
    View PubMed
  54. Kotwal A, Kudva YC. Letter to the Editor: "Checkpoint Inhibitor-Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes". J Clin Endocrinol Metab 2020 Jun 1; 105 (6)
    View PubMed
  55. Mbughuni MM, Stevens MA, Langman LJ, Kudva YC, Sanchez W, Dean PG, Jannetto PJ. Volumetric Microsampling of Capillary Blood Spot vs Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus and Cyclosporin A: Accuracy and Patient Satisfaction. J Appl Lab Med. 2020 May 1; 5 (3):516-530
    View PubMed
  56. Kovatchev B, Anderson SM, Raghinaru D, Kudva YC, Laffel LM, Levy C, Pinsker JE, Wadwa RP, Buckingham B, Doyle FJ 3rd, Brown SA, Church MM, Dadlani V, Dassau E, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Lum J, Beck RW, iDCL Study Group. Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care. 2020 Mar; 43 (3):607-615 Epub 2020 Jan 14
    View PubMed
  57. Kukla A, Hill J, Merzkani M, Bentall A, Lorenz EC, Park WD, D'Costa M, Kudva YC, Stegall MD, Shah P. The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients. Transplant Direct. 2020 Feb; 6 (2):e524 Epub 2020 Jan 13
    View PubMed
  58. Kudva YC, Nair KS. Diabetes Mellitus: A Perspective on the Post-Insulin Era. Mayo Clin Proc. 2020 Jan; 95 (1):15-21
    View PubMed
  59. Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, Dassau E, Doyle FJ 3rd, Anderson SM, Church MM, Dadlani V, Ekhlaspour L, Forlenza GP, Isganaitis E, Lam DW, Kollman C, Beck RW, iDCL Trial Research Group. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med. 2019 Oct 31; 381 (18):1707-1717 Epub 2019 Oct 16
    View PubMed
  60. Bharucha AE, Kudva YC, Prichard DO. Diabetic Gastroparesis. Endocr Rev. 2019 Oct 1; 40 (5):1318-1352
    View PubMed
  61. Kaiwar C, Kruisselbrink TM, Kudva YC, Klee EW, Pichurin P. Exome sequencing confirms diagnosis of kabuki syndrome in an-adult with hodgkin lymphoma and unusually severe multisystem phenotype. Clin Immunol. 2019 Oct; 207:55-57 Epub 2018 Sept 30
    View PubMed
  62. Dadlani V, Kaur RJ, Stegall M, Xyda SE, Kumari K, Bonner K, Smith B, Thapa P, Dean PG, Kudva YC. Continuous glucose monitoring to assess glycemic control in the first 6 weeks after pancreas transplantation. Clin Transplant. 2019 Oct; 33 (10):e13719 Epub 2019 Oct 11
    View PubMed
  63. Zhu Y, Tonne JM, Liu Q, Schreiber CA, Zhou Z, Rakshit K, Matveyenko AV, Terzic A, Wigle D, Kudva YC, Ikeda Y. Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive beta Cells Prior to Transplantation into Diabetic Recipients. Stem Cell Reports. 2019 Aug 13; 13 (2):307-321 Epub 2019 Aug 01
    View PubMed
  64. Anderson SM, Dassau E, Raghinaru D, Lum J, Brown SA, Pinsker JE, Church MM, Levy C, Lam D, Kudva YC, Buckingham B, Forlenza GP, Wadwa RP, Laffel L, Doyle FJ 3rd, DeVries JH, Renard E, Cobelli C, Boscari F, Del Favero S, Kovatchev BP. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability. Diabetes Technol Ther. 2019 Feb; 21 (2):73-80 Epub 2019 Jan 16
    View PubMed
  65. Kotwal A, Haddox C, Block M, Kudva YC. Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes. BMJ Open Diabetes Res Care. 2019; 7 (1):e000591 Epub 2019 Feb 13
    View PubMed
  66. Kudva YC, Ahmann AJ, Bergenstal RM, Gavin JR 3rd, Kruger DF, Midyett LK, Miller E, Harris DR. Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults. J Endocr Soc. 2018 Dec 1; 2 (12):1320-1337 Epub 2018 Nov 14
    View PubMed
  67. Hart PA, Andersen DK, Mather KJ, Castonguay AC, Bajaj M, Bellin MD, Bradley D, Contreras N, Habtezion A, Korc M, Kudva Y, Petrov MS, Whitcomb DC, Yadav D, Yuan Y, Rinaudo JAS, Srivastava S, Serrano J, Goodarzi MO, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas. 2018 Nov/Dec; 47 (10):1239-1243
    View PubMed
  68. Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S. Defining Outcomes for beta-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop. Transplantation. 2018 Sep; 102 (9):1479-1486
    View PubMed
  69. Dadlani V, Pinsker JE, Dassau E, Kudva YC. Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes. Curr Diab Rep. 2018 Aug 29; 18 (10):88
    View PubMed
  70. Nagpal SJS, Bamlet WR, Kudva YC, Chari ST. Comparison of Fasting Human Pancreatic Polypeptide Levels Among Patients With Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Type 2 Diabetes Mellitus. Pancreas. 2018 Jul; 47 (6):738-741
    View PubMed
  71. Lu B, Kurmi K, Munoz-Gomez M, Jacobus Ambuludi EJ, Tonne JM, Rakshit K, Hitosugi T, Kudva YC, Matveyenko AV, Ikeda Y. Impaired beta-cell glucokinase as an underlying mechanism in diet-induced diabetes. Dis Model Mech. 2018 Jun 13; 11 (6) Epub 2018 June 13
    View PubMed
  72. Ozaslan B, Patek SD, Grabman JH, Shepard JA, Dassau E, Breton MD, Kudva YC, Brown SA, Basu A, Pinsker JE, Doyle FJ 3rd, Gonder-Frederick L. Body Mass Index Effect on Differing Responses to Psychological Stress in Blood Glucose Dynamics in Patients With Type 1 Diabetes. J Diabetes Sci Technol. 2018 May; 12 (3):657-664 Epub 2018 Feb 08
    View PubMed
  73. Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S. Defining outcomes for beta-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop. Transpl Int. 2018 Apr; 31 (4):343-352
    View PubMed
  74. Dassau E, Pinsker JE, Kudva YC, Brown SA, Gondhalekar R, Dalla Man C, Patek S, Schiavon M, Dadlani V, Dasanayake I, Church MM, Carter RE, Bevier WC, Huyett LM, Hughes J, Anderson S, Lv D, Schertz E, Emory E, McCrady-Spitzer SK, Jean T, Bradley PK, Hinshaw L, Laguna Sanz AJ, Basu A, Kovatchev B, Cobelli C, Doyle FJ 3rd. Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia. Diabetes Care. 2017 Dec; 40(12):1719-1726. Epub 2017 Oct 13.
    View PubMed
  75. Zhang Y, Ma R, Zhen XV, Kudva YC, Buhlmann P, Koester SJ. Capacitive Sensing of Glucose in Electrolytes Using Graphene Quantum Capacitance Varactors. ACS Appl Mater Interfaces. 2017 Nov 8; 9 (44):38863-38869 Epub 2017 Oct 24
    View PubMed
  76. Brown SA, Breton MD, Anderson SM, Kollar L, Keith-Hynes P, Levy CJ, Lam DW, Levister C, Baysal N, Kudva YC, Basu A, Dadlani V, Hinshaw L, McCrady-Spitzer S, Bruttomesso D, Visentin R, Galasso S, Del Favero S, Leal Y, Boscari F, Avogaro A, Cobelli C, Kovatchev BP. Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes. J Clin Endocrinol Metab. 2017 Oct 01; 102(10):3674-3682.
    View PubMed
  77. Dadlani V, Tamhane SU, Sun A, Sharma A, Delivanis DA, Thapa P, Carter RE, Kudva YC. High Glucose Variability in Hospitalized Patients with Type 1 Diabetes Mellitus. Diabetes Technol Ther. 2017 Oct; 19 (10):572-579
    View PubMed
  78. Dadlani V, Kudva YC. Assessment of Interday Glucose Variability in Type 2 Diabetes. Diabetes Technol Ther 2017 Aug; 19 (8):443-445
    View PubMed
  79. Mukewar S, Sharma A, Lackore KA, Enders FT, Torbenson MS, Kamath PS, Roberts LR, Kudva YC. Clinical, Biochemical, and Histopathology Features of Patients With Glycogenic Hepatopathy. Clin Gastroenterol Hepatol. 2017 Jun; 15 (6):927-933 Epub 2016 Dec 30
    View PubMed
  80. Cramer AM, Scalzo P, Bach SM, Kudva YC. Patient- and Provider-Centered Design of an Outpatient Diabetes Technology Clinic. J Diabetes Sci Technol. 2017 May; 11 (3):499-505 Epub 2016 Oct 09
    View PubMed
  81. Dean PG, Kukla A, Stegall MD, Kudva YC. Pancreas transplantation. BMJ. 2017 Apr 3; 357:j1321 Epub 2017 Apr 03
    View PubMed
  82. Dean PG, Kukla A, Stegall MD, Kudva YC. Pancreas transplantation BMJ-British Medical Journal. 2017 Apr 3; 357:j1321.
  83. Parthasarathy G, Kudva YC, Low PA, Camilleri M, Basu A, Bharucha AE. Relationship Between Gastric Emptying and Diurnal Glycemic Control in Type 1 Diabetes Mellitus: A Randomized Trial. J Clin Endocrinol Metab. 2017 Feb 1; 102 (2):398-406
    View PubMed
  84. Chakkera HA, Kudva Y, Kaplan B. Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus. Clin Pharmacol Ther. 2017 Jan; 101 (1):114-120 Epub 2016 Nov 21
    View PubMed
  85. Zhang Y, Ma R, Kudva YC, Buhlmann P, Koester S. Glucose sensing with graphene varactors Proceedings of IEEE Sensors. 2017; 7808854.
  86. Parthasarathy G, Kudva YC, Low PA, Camilleri M, Basu A, Bharucha AE. Relationship between gastric emptying and diurnal glycemic control in type 1 diabetes mellitus: A randomized trial Journal of Clinical Endocrinology and Metabolism. 2017; 102: (2)398-406.
  87. Hart PA, Bellin MD, Andersen DK, Bradley D, Cruz-Monserrate Z, Forsmark CE, Goodarzi MO, Habtezion A, Korc M, Kudva YC, Pandol SJ, Yadav D, Chari ST, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer(CPDPC). Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016 Nov; 1 (3):226-237 Epub 2016 Oct 12
    View PubMed
  88. Simha V, Kudva YC. HDL Cholesterol Story Is Dead: Long Live HDL! Diabetes 2016 Oct; 65 (10):2826-8
    View PubMed
  89. Manjunatha S, Distelmaier K, Dasari S, Carter RE, Kudva YC, Nair KS. Functional and proteomic alterations of plasma high density lipoproteins in type 1 diabetes mellitus. Metabolism. 2016 Sep; 65 (9):1421-31 Epub 2016 June 29
    View PubMed
  90. Mohapatra S, Majumder S, Smyrk TC, Zhang L, Matveyenko A, Kudva YC, Chari ST. Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy: Conclusions From a Review of Literature. Pancreas. 2016 Sep; 45 (8):1104-10
    View PubMed
  91. Dadlani V, Kudva YC. Continuous Glucose Monitor Use and Accuracy in Hospitalized Patients. Diabetes Technol Ther. 2016 Aug; 18 (8):449-51 Epub 2016 Aug 08
    View PubMed
  92. Cartee AK, Owens LA, Lahr BD, Yawn BP, Murray JA, Kudva YC. Incidence of Type 1 Diabetes Is Not Increasing in a Population-Based Cohort in Olmsted County, Minnesota, USA. Mayo Clin Proc. 2016 Aug; 91 (8):1066-73
    View PubMed
  93. Dadlani V, Kudva YC. Role of Automation/Technology in Day-to-Day Diabetes Care. Diabetes Technol Ther. 2016 May; 18 (5):273-5 Epub 2016 Mar 30
    View PubMed
  94. El Khatib MM, Ohmine S, Jacobus EJ, Tonne JM, Morsy SG, Holditch SJ, Schreiber CA, Uetsuka K, Fusaki N, Wigle DA, Terzic A, Kudva YC, Ikeda Y. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration. Stem Cells Transl Med. 2016 May; 5 (5):694-702 Epub 2016 Mar 17
    View PubMed
  95. Gonder-Frederick LA, Grabman JH, Kovatchev B, Brown SA, Patek S, Basu A, Pinsker JE, Kudva YC, Wakeman CA, Dassau E, Cobelli C, Zisser HC, Doyle FJ 3rd. Is Psychological Stress a Factor for Incorporation Into Future Closed-Loop Systems? J Diabetes Sci Technol. 2016 May; 10 (3):640-6 Epub 2016 May 03
    View PubMed
  96. Hinshaw L, Schiavon M, Dadlani V, Mallad A, Dalla Man C, Bharucha A, Basu R, Geske JR, Carter RE, Cobelli C, Basu A, Kudva YC. Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes. J Clin Endocrinol Metab. 2016 May; 101 (5):1954-62 Epub 2016 Mar 01
    View PubMed
  97. Dutta T, Kudva YC, Persson XM, Schenck LA, Ford GC, Singh RJ, Carter R, Nair KS. Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People. J Clin Endocrinol Metab. 2016 Mar; 101 (3):1023-33 Epub 2016 Jan 21
    View PubMed
  98. Chakkera HA, Kudva YC, Chang YH, Heilman RL, Singer AL, Mathur AK, Hewitt WR, Khamash HA, Huskey JL, Katariya NN, Moss AA, Behmen S, Reddy KS. Glucose homeostasis after simultaneous pancreas and kidney transplantation: a comparison of subjects with C-peptide-positive non-type 1 diabetes mellitus and type 1 diabetes mellitus. Clin Transplant. 2016 Jan; 30: (1)52-9.
    View PubMed
  99. Schiavon M, Dalla Man C, Dube S, Slama M, Kudva YC, Peyser T, Basu A, Basu R, Cobelli C. Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data. Diabetes Technol Ther. 2015 Nov; 17 (11):825-31 Epub 2015 Aug 27
    View PubMed
  100. Dadlani V, Levine JA, McCrady-Spitzer SK, Dassau E, Kudva YC. Physical Activity Capture Technology With Potential for Incorporation Into Closed-Loop Control for Type 1 Diabetes. J Diabetes Sci Technol. 2015 Oct 18; 9(6):1208-16.
    View PubMed
  101. Dassau E, Brown SA, Basu A, Pinsker JE, Kudva YC, Gondhalekar R, Patek S, Lv D, Schiavon M, Lee JB, Dalla Man C, Hinshaw L, Castorino K, Mallad A, Dadlani V, McCrady-Spitzer SK, McElwee-Malloy M, Wakeman CA, Bevier WC, Bradley PK, Kovatchev B, Cobelli C, Zisser HC, Doyle FJ 3rd. Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial. J Clin Endocrinol Metab. 2015 Oct; 100(10):3878-86. Epub 2015 Jul 23.
    View PubMed
  102. O'Keeffe DT, Maraka S, Basu A, Keith-Hynes P, Kudva YC. Cybersecurity in Artificial Pancreas Experiments. Diabetes Technol Ther. 2015 Sep; 17 (9):664-6 Epub 2015 Apr 29
    View PubMed
  103. Hinshaw L, Mallad A, Dalla Man C, Basu R, Cobelli C, Carter RE, Kudva YC, Basu A. Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments. Am J Physiol Endocrinol Metab. 2015 Sep 1; 309 (5):E474-86 Epub 2015 July 07
    View PubMed
  104. Mallad A, Hinshaw L, Dalla Man C, Cobelli C, Basu R, Lingineni R, Carter RE, Kudva YC, Basu A. Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches. Diabetes Technol Ther. 2015 Aug; 17 (8):587-95 Epub 2015 June 29
    View PubMed
  105. Mallad A, Hinshaw L, Schiavon M, Dalla Man C, Dadlani V, Basu R, Lingineni R, Cobelli C, Johnson ML, Carter R, Kudva YC, Basu A. Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approach. Am J Physiol Endocrinol Metab. 2015 Jun 15; 308 (12):E1106-15 Epub 2015 Apr 21
    View PubMed
  106. El Khatib MM, Sakuma T, Tonne JM, Mohamed MS, Holditch SJ, Lu B, Kudva YC, Ikeda Y. beta-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection. Gene Ther. 2015 May; 22 (5):430-8 Epub 2015 Mar 19
    View PubMed
  107. Hart PA, Baichoo E, Bi Y, Hinton A, Kudva YC, Chari ST. Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus. Pancreatology. 2015 Mar-Apr; 15 (2):162-6 Epub 2015 Feb 24
    View PubMed
  108. Maraka S, Kudva YC, Kellogg TA, Collazo-Clavell ML, Mundi MS. Bariatric surgery and diabetes: Implications of type 1 versus insulin-requiring type 2. Obesity (Silver Spring). 2015 Mar; 23 (3):552-7 Epub 2015 Jan 22
    View PubMed
  109. Bharucha AE, Kudva Y, Basu A, Camilleri M, Low PA, Vella A, Zinsmeister AR. Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes. Clin Gastroenterol Hepatol. 2015 Mar; 13 (3):466-476.e1 Epub 2014 July 17
    View PubMed
  110. Tonne JM, Sakuma T, Munoz-Gomez M, El Khatib M, Barry MA, Kudva YC, Ikeda Y. Beta cell regeneration after single-round immunological destruction in a mouse model. Diabetologia. 2015 Feb; 58 (2):313-23 Epub 2014 Oct 23
    View PubMed
  111. Schiavon M, Dalla Man C, Kudva YC, Basu A, Cobelli C. Quantitative estimation of insulin sensitivity in type 1 diabetic subjects wearing a sensor-augmented insulin pump. Diabetes Technology and Therapeutics. 2015; 17:S13.
  112. Basu A, Dube S, Veettil S, Slama M, Kudva YC, Peyser T, Carter RE, Cobelli C, Basu R. Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes. J Diabetes Sci Technol. 2015 Jan; 9 (1):63-8 Epub 2014 Oct 10
    View PubMed
  113. Visentin R, Dalla Man C, Kudva YC, Basu A, Cobelli C. Circadian variability of insulin sensitivity: Physiological input for in silico artificial pancreas. Diabetes Technology and Therapeutics. 2015; 17(1):1-7.
    View PubMed
  114. Bonner KP, Kudva YC, Stegall MD, Dean PG. Should We Be Performing More Pancreas Transplants? Clin Transpl. 2015; 31:173-180
    View PubMed
  115. Hinshaw L, Schiavon M, Mallad A, Man CD, Basu R, Bharucha AE, Cobelli C, Carter RE, Basu A, Kudva YC. Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and beta-cell function. Am J Physiol Endocrinol Metab. 2014 Sep 15; 307 (6):E494-502 Epub 2014 July 29
    View PubMed
  116. Keddis MT, El Ters M, Rodrigo E, Dean P, Wohlfahrtova M, Dean P, Kudva YC, Lorenz EC, Cosio FG. Enhanced posttransplant management of patients with diabetes improves patient outcomes. Kidney Int. 2014 Sep; 86 (3):610-8 Epub 2014 Apr 02
    View PubMed
  117. Kudva YC, Carter RE, Cobelli C, Basu R, Basu A. Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices. Diabetes Care. 2014; 37(5):1184-90.
    View PubMed
  118. Buse JB, Kudva YC, Battelino T, Davis SN, Shin J, Welsh JB. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technology and Therapeutics. 2014; 16(Suppl 1):S103.
  119. Schiavon M, Dalla Man C, Kudva YC, Basu A, Cobelli C. Quantitative estimation of insulin sensitivity in type 1 diabetic subjects wearing a sensor-augmented insulin pump. Diabetes Care. 2014; 37(5):1216-23.
    View PubMed
  120. Chauhan A, Diwan TS, Franco Palacios CR, Dean PG, Heimbach JK, Chow GK, Prieto M, Cosio FG, Taler SJ, Textor SC, Kudva YC, Cornell LD, Stegall MD. Using implantation biopsies as a surrogate to evaluate selection criteria for living kidney donors. Transplantation. 2013 Dec 15; 96 (11):975-80
    View PubMed
  121. Basu A, Dube S, Slama M, Errazuriz I, Amezcua JC, Kudva YC, Peyser T, Carter RE, Cobelli C, Basu R. Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes. 2013 Dec; 62 (12):4083-7 Epub 2013 Sept 05
    View PubMed
  122. Zecchin C, Facchinetti A, Sparacino G, Dalla Man C, Manohar C, Levine JA, Basu A, Kudva YC, Cobelli C. Physical activity measured by physical activity monitoring system correlates with glucose trends reconstructed from continuous glucose monitoring. Diabetes Technol Ther. 2013 Oct; 15(10):836-44. Epub 2013 Aug 14.
    View PubMed
  123. Manohar C, O'Keeffe DT, Hinshaw L, Lingineni R, McCrady-Spitzer SK, Levine JA, Carter RE, Basu A, Kudva YC. Comparison of physical activity sensors and heart rate monitoring for real-time activity detection in type 1 diabetes and control subjects. Diabetes Technol Ther. 2013 Sep; 15(9):751-7. Epub 2013 Aug 12.
    View PubMed
  124. Tonne JM, Sakuma T, Deeds MC, Munoz-Gomez M, Barry MA, Kudva YC, Ikeda Y. Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced beta-cell damage and pancreatic Glp-1 gene therapy. Dis Model Mech. 2013 Sep; 6 (5):1236-45 Epub 2013 July 04
    View PubMed
  125. Schiavon M, Hinshaw L, Mallad A, Dalla Man C, Sparacino G, Johnson M, Carter R, Basu R, Kudva Y, Cobelli C, Basu A. Postprandial glucose fluxes and insulin sensitivity during exercise: a study in healthy individuals. Am J Physiol Endocrinol Metab. 2013 Aug 15; 305 (4):E557-66 Epub 2013 July 02
    View PubMed
  126. Hinshaw L, Dalla Man C, Nandy DK, Saad A, Bharucha AE, Levine JA, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes. 2013 Jul; 62 (7):2223-9 Epub 2013 Feb 27
    View PubMed
  127. Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB. Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease. Stroke. 2013 Jul; 44 (7):1997-9 Epub 2013 May 07
    View PubMed
  128. Kudva YC, Erickson JR, Parsaik A, Rostambeigi N, Thapa P, Abraham RS. Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients. Hum Immunol. 2013 Jun; 74(6):738-45. Epub 2013 Mar 07.
    View PubMed
  129. Bharucha AE, Low P, Camilleri M, Veil E, Burton D, Kudva Y, Shah P, Gehrking T, Zinsmeister AR. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013 May; 62 (5):708-15 Epub 2012 June 07
    View PubMed
  130. Dong M, Parsaik AK, Kremers W, Sun A, Dean P, Prieto M, Cosio FG, Gandhi MJ, Zhang L, Smyrk TC, Stegall MD, Kudva YC. Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation. Am J Transplant. 2013 Apr; 13 (4):1019-1025 Epub 2013 Feb 22
    View PubMed
  131. Ferrara MJ, Lohse C, Kudva YC, Farnell MB, Que FG, Reid-Lombardo KM, Donohue JH, Nagorney DM, Chari ST, Vege SS, Kendrick ML. Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB (Oxford). 2013 Mar; 15 (3):170-4 Epub 2012 Sept 10
    View PubMed
  132. Basu A, Kudva YC, Basu R. GPR40 modulators: new kid on the block. Diabetes Care. 2013 Feb; 36 (2):185-7
    View PubMed
  133. Schiavon M, Dalla Man C, Kudva YC, Basu A, Cobelli C. In silico optimization of basal insulin infusion rate during exercise: Implication for artificial pancreas. Journal of Diabetes Science and Technology. 2013; 7(6):1461-9.
    View PubMed
  134. Thatava T, Kudva YC, Edukulla R, Squillace K, De Lamo JG, Khan YK, Sakuma T, Ohmine S, Terzic A, Ikeda Y. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther. 2013 Jan; 21 (1):228-39 Epub 2012 Nov 27
    View PubMed
  135. Parsaik AK, Carter RE, Myers LA, Basu A, Kudva YC. Hypoglycemia requiring ambulance services in patients with type 2 diabetes is associated with increased long-term mortality. Endocr Pract. 2013 Jan-Feb; 19 (1):29-35
    View PubMed
  136. Marietta EV, Gomez AM, Yeoman C, Tilahun AY, Clark CR, Luckey DH, Murray JA, White BA, Kudva YC, Rajagopalan G. Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS One. 2013; 8 (11):e78687 Epub 2013 Nov 13
    View PubMed
  137. Olson EJ, Deen DA, Ebrish MA, Basu A, Kudva YC, Mukherjee P, Koester SJ. Wireless graphene-based quantum capacitance sensors for continuous glucose monitoring. Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. 2013; 2:111-4.
  138. Manohar C, Levine JA, Nandy DK, Saad A, Dalla Man C, McCrady-Spitzer SK, Basu R, Cobelli C, Carter RE, Basu A, Kudva YC. The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people. Diabetes Care. 2012 Dec; 35(12):2493-9. Epub 2012 Aug 08.
    View PubMed
  139. Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes. 2012 Nov; 61 (11):2691-700 Epub 2012 June 29
    View PubMed
  140. Parsaik AK, Carter RE, Myers LA, Geske JR, Smith SA, Levine JA, Basu A, Kudva YC. Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. Endocr Pract. 2012 Nov-Dec; 18 (6):834-41
    View PubMed
  141. Spanogle JP, Kudva YC, Dierkhising RA, Kremers WK, Roenigk RK, Brewer JD, Prieto M, Otley CC. Skin cancer after pancreas transplantation. J Am Acad Dermatol. 2012 Oct; 67 (4):563-9 Epub 2012 Feb 15
    View PubMed
  142. Parsaik AK, Carter RE, Myers LA, Dong M, Basu A, Kudva YC. Outcomes of community-dwelling adults without diabetes mellitus who require ambulance services for hypoglycemia. J Diabetes Sci Technol. 2012 Sep 1; 6 (5):1107-13 Epub 2012 Sept 01
    View PubMed
  143. Wauters RP, Cosio FG, Suarez Fernandez ML, Kudva Y, Shah P, Torres VE. Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation. Transplantation. 2012 Aug 27; 94 (4):377-82
    View PubMed
  144. Buse JB, Kudva YC, Battelino T, Davis SN, Shin J, Welsh JB. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther. 2012 Jul; 14(7):644-7. Epub 2012 Apr 23.
    View PubMed
  145. Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M, Pattou F, Berney T, Secchi A, Messinger S, Senior PA, Maffi P, Posselt A, Stock PG, Kaufman DB, Luo X, Kandeel F, Cagliero E, Turgeon NA, Witkowski P, Naji A, O'Connell PJ, Greenbaum C, Kudva YC, Brayman KL, Aull MJ, Larsen C, Kay TW, Fernandez LA, Vantyghem MC, Bellin M, Shapiro AM. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care. 2012 Jul; 35(7):1436-45.
    View PubMed
  146. Dong M, Parsaik AK, Eberhardt NL, Basu A, Cosio FG, Kudva YC. Cellular and physiological mechanisms of new-onset diabetes mellitus after solid organ transplantation. Diabet Med. 2012 Jul; 29 (7):e1-12
    View PubMed
  147. Kudva YC, Ohmine S, Greder LV, Dutton JR, Armstrong A, De Lamo JG, Khan YK, Thatava T, Hasegawa M, Fusaki N, Slack JM, Ikeda Y. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Transl Med. 2012 Jun; 1 (6):451-61 Epub 2012 May 30
    View PubMed
  148. Dutta T, Chai HS, Ward LE, Ghosh A, Persson XM, Ford GC, Kudva YC, Sun Z, Asmann YW, Kocher JP, Nair KS. Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes. 2012 May; 61: (5)1004-16.
    View PubMed
  149. Hiddinga HJ, Sakagashira S, Ishigame M, Madde P, Sanke T, Nanjo K, Kudva YC, Lee JJ, van Deursen J, Eberhardt NL. Expression of wild-type and mutant S20G hIAPP in physiologic knock-in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance. J Diabetes Investig. 2012 Mar 28; 3 (2):138-47
    View PubMed
  150. Ohmine S, Squillace KA, Hartjes KA, Deeds MC, Armstrong AS, Thatava T, Sakuma T, Terzic A, Kudva Y, Ikeda Y. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging (Albany NY). 2012 Jan; 4 (1):60-73
    View PubMed
  151. Parsaik AK, Carter RE, Pattan V, Myers LA, Kumar H, Smith SA, Russi CS, Levine JA, Basu A, Kudva YC. Population-based study of severe hypoglycemia requiring emergency medical service assistance reveals unique findings. J Diabetes Sci Technol. 2012 Jan 1; 6 (1):65-73 Epub 2012 Jan 01
    View PubMed
  152. Thatava T, Armstrong AS, De Lamo JG, Edukulla R, Khan YK, Sakuma T, Ohmine S, Sundsbak JL, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Res Ther. 2011 Dec 6; 2 (6):48 Epub 2011 Dec 06
    View PubMed
  153. Dong M, Parsaik AK, Erwin PJ, Farnell MB, Murad MH, Kudva YC. Systematic review and meta-analysis: islet autotransplantation after pancreatectomy for minimizing diabetes. Clin Endocrinol (Oxf). 2011 Dec; 75 (6):771-9
    View PubMed
  154. Ohmine S, Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T, Sakuma T, Kudva YC, Ikeda Y. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Res Ther. 2011 Nov 16; 2 (6):46
    View PubMed
  155. Parsaik AK, Bhalla T, Dong M, Rostambeigi N, Dierkhising RA, Dean P, Abraham R, Prieto M, Kremers WK, Razonable RR, Kudva YC. Epidemiology of cytomegalovirus infection after pancreas transplantation. Transplantation. 2011 Nov 15; 92(9):1044-50.
    View PubMed
  156. Pattan V, Parsaik A, Brown JK, Kudva YC, Vlahakis N, Basu A. Glucose control in Mayo Clinic intensive care units. J Diabetes Sci Technol. 2011 Nov 1; 5 (6):1420-6 Epub 2011 Nov 01
    View PubMed
  157. Gandhi GY, Kovalaske M, Kudva Y, Walsh K, Elamin MB, Beers M, Coyle C, Goalen M, Murad MS, Erwin PJ, Corpus J, Montori VM, Murad MH. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol. 2011 Jul 1; 5 (4):952-65 Epub 2011 July 01
    View PubMed
  158. Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, Eberhardt NL, Kudva YC. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim. 2011 Jul; 45 (3):131-40 Epub 2011 Apr 08
    View PubMed
  159. Rostambeigi N, Lanza IR, Dzeja PP, Deeds MC, Irving BA, Reddi HV, Madde P, Zhang S, Asmann YW, Anderson JM, Schimke JM, Nair KS, Eberhardt NL, Kudva YC. Unique cellular and mitochondrial defects mediate FK506-induced islet beta-cell dysfunction. Transplantation. 2011 Mar 27; 91 (6):615-23
    View PubMed
  160. Thatava T, Nelson TJ, Edukulla R, Sakuma T, Ohmine S, Tonne JM, Yamada S, Kudva Y, Terzic A, Ikeda Y. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther. 2011 Mar; 18 (3):283-93 Epub 2010 Nov 04
    View PubMed
  161. Dong M, Parsaik AK, Eberhardt NL, Basu A, Cosio FG, Kudva YC. Cellular and Physiologic Mechanisms of New Onset Diabetes Mellitus after Solid Organ Transplantation. Diab Med (. 2011; In Press).
  162. Pattan V, Parsaik AK, Brown JK, Kudva YC, Vlahakis N, Basu A. Mayo Clinic Experience: Insulin Infusion Protocol with significantly reduced Hypoglycemia in the Intensive Care Unit. Journal of Diabetes Science and Technology (. 2011; In Press).
  163. Hiddinga HJ, Sakagashira S, Ishigame M, Madde P, Sanke T, Nanjo K, Kudva YC, Lee JL, van Deursen J, Eberhardt NL. Expression of wild-type and mutant S20G hIAPP in physiologic knock-in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance. Journal of Diabetes Investigation J Diab Invest (. 2011; In Press).
  164. Spanogle JP, Kudva YC, Dierkhising RA, Kremers WK, Roenigk RK, Brewer JD, Prieto M, Otley CC. Skin Cancer Following Pancreas Transplant. Journal of the American Academy of Dermatology (. 2011; In Press).
  165. Parsaik AK, Carter RE, Pattan V, Myers LA, Kumar H, Smith SA, Russi CS, Levine JA, Basu A, Kudva YC. Population Based Study of Severe Hypoglycemia requiring Emergency Medical Service Assistance reveals Unique Findings. J Diab Sci Tech (. 2011; In Press).
  166. Thatava T, Armstrong A, De Lamo JG, Edukulla R, Sakuma T, Ohmine S, Sundsbak J, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific iPS cell generation from patients with kidney transplantation. Stem Cell Research and Therapy (. 2011; In Press).
  167. Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza RA, Basu R, Cobelli C, Kudva YC, Basu A. Circadian Pattern to Insulin Secretion and Insulin Action in healthy individuals. Diabetes (. 2011; revision submitted).
  168. Eckel-Passow JE, Mahoney DW, Oberg AL, Zenka RM, Johnson KL, Nair KS, Kudva YC, Bergen HR 3rd, Therneau TM. Bi-Linear Regression for O Quantification: Modeling across the Elution Profile. J Proteomics Bioinform. 2010 Dec 15; 3(12):314-320.
    View PubMed
  169. Parsaik AK, Murad MH, Sathananthan A, Moorthy V, Erwin PJ, Chari S, Carter RE, Farnell MB, Vege SS, Sarr MG, Kudva YC. Metabolic and target organ outcomes after total pancreatectomy: Mayo Clinic experience and meta-analysis of the literature. Clin Endocrinol (Oxf). 2010 Dec; 73(6):723-31.
    View PubMed
  170. Rostambeigi N, Kudva YC, John S, Mailankody S, Pedersen RA, Dean PG, Prieto M, Cosio FG, Kremers WK, Walker RC, Abraham RS, Stegall MD. Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Transplantation. 2010 May 15; 89 (9):1126-33
    View PubMed
  171. Issa N, Amer H, Dean PG, Kremers WK, Kudva YC, Rostambeigi N, Cosio FG, Larson TS, Habermann TM, Stegall MD, Griffin MD. Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant. 2009 Aug; 9 (8):1894-902 Epub 2009 June 10
    View PubMed
  172. Winters JL, Tran SA, Gastineau DA, Padley DJ, Dean PG, Kudva YC. Organ procurement organization compliance with 21 CFR 1271: a challenge for allogeneic pancreatic islet cell transplantation programs. Am J Transplant. 2009 Jun; 9 (6):1472-6 Epub 2009 May 13
    View PubMed
  173. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab. 2009 Mar; 94 (3):729-40 Epub 2008 Dec 16
    View PubMed
  174. Fatourechi M, Kudva YC, Hassan Murad M, Tabini C, Montori VM. Intensive insulin therapy with continuous subcutaneous insulin infusion versus multiple daily injections: systematic review and meta-analysis of randomized controlled trials. J Clin Endo Metab ePub. Dec. 2008.
  175. Gandhi GY, Murad MH, Flynn DN, Elamin MB, Erwin PJ, Montori VM, Kudva YC. Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials. Clin Endocrinol (Oxf). 2008 Aug; 69 (2):244-52 Epub 2008 Jan 10
    View PubMed
  176. Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr; 31(4):643-7. Epub 2008 Jan 09.
    View PubMed
  177. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant. 2008 Mar; 8 (3):593-9
    View PubMed
  178. Dean PG, Kudva YC, Stegall MD. Long-term benefits of pancreas transplantation. Curr Opin Organ Transplant. 2008 Feb; 13(1):85-90.
    View PubMed
  179. Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD. Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant. 2008 Jan; 8 (1):175-82 Epub 2007 Oct 31
    View PubMed
  180. Rajagopalan G, Mangalam AK, Sen MM, Kudva YC, David CS. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes. Autoimmunity. 2007 Nov; 40 (7):489-96
    View PubMed
  181. Ajaz F, Kudva YC, Erwin PJ. Residual dysphasia after severe hypoglycemia in a patient with immune-mediated primary adrenal insufficiency and type 1 diabetes mellitus: case report and systematic review of the literature. Endocr Pract. 2007 Jul-Aug; 13(4):384-8.
    View PubMed
  182. Rajagopalan G, Mangalam AK, Sen MM, Cheng S, Kudva YC, David CS. Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans. Autoimmunity. 2007 May; 40(3):169-79.
    View PubMed
  183. Kudva YC, Basu A, Jenkins GD, Pons GM, Vogelsang DA, Rizza RA, Smith SA, Isley WL. Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin. Endocr Pract. 2007 May-Jun; 13 (3):244-50
    View PubMed
  184. Pissios P, Ozcan U, Kokkotou E, Okada T, Liew CW, Liu S, Peters JN, Dahlgren G, Karamchandani J, Kudva YC, Kurpad AJ, Kennedy RT, Maratos-Flier E, Kulkarni RN. Melanin concentrating hormone is a novel regulator of islet function and growth. Diabetes. 2007 Feb; 56(2):311-9.
    View PubMed
  185. Anderson JM, Deeds MC, Armstrong AS, Gastineau DA, Kudva YC. Utilization of a test gradient enhances islet recovery from deceased donor pancreases. Cytotherapy. 2007; 9(7):630-6.
    View PubMed
  186. Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, Vogelsang DA, Smith SA, Rizza RA, Isley WL. Glycemic Variation and Hypoglycemia in well controlled patients with type 1 diabetes on Multiple Daily Insulin Injection Program using Glargine and Ultralente as basal insulin. Diabetes Research and Clin Practice. 2007.
  187. Rajagopalan G, Kudva YC, Sen MM, Marietta EV, Murali N, Nath K, Moore J, David CS. IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice. Cytokine. 2006 Apr; 34(1-2):85-95.
    View PubMed
  188. Mahmud FH, Murray JA, Kudva YC, Zinsmeister AR, Dierkhising RA, Lahr BD, Dyck PJ, Kyle RA, El-Youssef M, Burgart LJ, Van Dyke CT, Brogan DL, Melton LJ 3rd. Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc. 2005 Nov; 80 (11):1429-34
    View PubMed
  189. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005 Jun; 67 (6):2415-21
    View PubMed
  190. Heimbach JK, Taler SJ, Prieto M, Cosio FG, Textor SC, Kudva YC, Chow GK, Ishitani MB, Larson TS, Stegall MD. Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant. 2005 May; 5 (5):1057-64
    View PubMed
  191. Krajicek BJ, Kudva YC. Hurley HA. Potentially important contribution of dextrose used as diluent to hyperglycemia in hospitalized patients Diabetes Care. 2005; 28(4):981-2.
  192. Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, Vogelsang DA, Smith SA, Rizza RA, Isley WL. Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes. Diabetes Care. 2005 Jan; 28 (1):10-4
    View PubMed
  193. Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC. Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care. 2004 May; 27 (5):1088-94
    View PubMed
  194. Larson TS, Bohorquez H, Rea DJ, Nyberg SL, Prieto M, Sterioff S, Textor SC, Schwab TR, Griffin MD, Gloor JM, Kudva YC, Kremers WK, Stegall MD. Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation. 2004 Mar 27; 77 (6):838-43
    View PubMed
  195. Kudva YC, Sawka AM, Young WF Jr. Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. 2003 Oct; 88 (10):4533-9
    View PubMed
  196. Rajagopalan G, Kudva YC, Chen L, Wen L, David CS. Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans. Int Immunol. 2003 Sep; 15 (9):1035-44
    View PubMed
  197. Zangeneh F, Kudva YC, Basu A. Insulin sensitizers. Mayo Clin Proc. 2003 Apr; 78: (4)471-9.
    View PubMed
  198. Rajagopalan G, Kudva YC, Flavell RA, David CS. Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Diabetes. 2003 Feb; 52 (2):342-7
    View PubMed
  199. Kudva YC, Reynolds CA, O'Brien T, Crotty TB. Mastopathy and diabetes. Curr Diab Rep. 2003 Feb; 3 (1):56-9
    View PubMed
  200. Kudva YC, Rajagopalan G, Raju R, Abraham RS, Smart M, Hanson J, David CS. Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II. Hum Immunol. 2002 Nov; 63 (11):987-99
    View PubMed
  201. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002 Mar; 25 (3):583-92
    View PubMed
  202. Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB. "Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. Diabetes Care. 2002 Jan; 25 (1):121-6
    View PubMed
  203. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF Jr. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 2001 Nov; 86 (11):5210-6
    View PubMed
  204. Kudva YC, Deng YJ, Govindarajan R, Govindarajan R, Abraham RS, Marietta EV, Notkins AL, David CS. HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2. Hum Immunol. 2001 Oct; 62 (10):1099-105
    View PubMed
  205. Kudva YC, Deng Y, Govindrajan R, Abraham RS, Marietta E, Notkins AL, David CS. The Cytoplasmic Region of IA-2 are Immunogenic in NOD and HLA DQ8 Transgenic Mice. Human Immunol. 2001; 62(10):1099-105.
  206. Abraham RS, Kudva YC, Wilson SB, Strominger JL, David CS. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes. 2000 Apr; 49 (4):548-54
    View PubMed
  207. Stegall MD, Larson TS, Kudva YC, Grande JP, Nyberg SL, Prieto M, Velosa JA, Rizza RA. Pancreas transplantation for the prevention of diabetic nephropathy. Mayo Clin Proc. 2000 Jan; 75(1):49-56.
    View PubMed
  208. Kudva YC, O'Brien T, Crotty TB. Sclerosing lymphocytic lobulitis or "diabetic mastopathy" is specific for type 1 diabetes mellitus. Diabetes Care. 2000.
  209. Kudva YC, Young WF, Thompson GB, Grant CS, van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist. 1999 Mar-Apr; 9(2):77-80.
  210. Kudva YC, Mueske C, Butler PC, Eberhardt NL. A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation. Biochem J. 1998 May 1; 331 ( Pt 3):809-13
    View PubMed
  211. Kudva YC, Gharib H. Thyroid nodules: approaches to diagnosis and management. Endocr Updates. 1998; 2:139-154.
  212. Kudva YC, Mueske CS, Butler PC, Eberhardt NL. Effect of Insulin Secretory Vesicle Constituents on Human Islet Amyloid Polypeptide (IAPP) Amyloidogenesis in an In vitro Fluorescence Assay. Biochem J 331 809-13,. 1998.
  213. Kudva YC, Young WF Jr. Lightheaded spells and hypertension. Lancet. 1997 Oct 18; 350(9085):1140.
    View PubMed
  214. Kudva YC, Hiddinga HJ, Butler PC, Mueske CS, Eberhardt NL. Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis. FEBS Lett. 1997 Oct 13; 416 (1):117-21
    View PubMed
  215. Kudva YC, Peterson LS, Holley KE, Wright AJ, Hunder GG. SLE nephropathy in a patient with HIV infection: case report and review of the literature. J Rheumatol. 1996 Oct; 23 (10):1811-5
    View PubMed
  216. Kudva YC, Mason TG. 22-year-old man with abdominal pain and rash. Mayo Clin Proc. 1996 May; 71 (5):489-92
    View PubMed
  217. Chintapatla S, Kudva YC, Nayar RC, Raghuveer TS, Prasad D. Septal deviation in neonates. Indian Pediatr. 1989 Jul; 26(7):678-82.
    View PubMed